|Articles|April 28, 2023
Trends in Bio/Pharma Facilities: Ken Gilmartin Gives His Perspective (INTERPHEX 2023)
Wood CEO Ken Gilmartin gives his insight on what's currently in demand in terms of new bio/pharma manufacturing facilities.
Advertisement
Ken Gilmartin, CEO, Wood, gives his insight on what's currently in demand in terms of new bio/pharma manufacturing facilities. He emphasizes that a significant amount of capital is being invested in the United States for facilities, particularly in the large molecule and cell and gene therapy sectors.
For more INTERPHEX 2023 video content, check
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Rare Disease Treatments: Navigating the Economics of Global Innovation
2
WEF Welcomes ACG Shirwal as First Pharma Packaging Site in Global Lighthouse Network
3
Women in STEM: Early Phase Drug Development
4
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
5